|
DUBLIN(BUSINESS WIRE)
Research and Markets (http://www.researchandmarkets.com/research/4wwjmk/9th-annual-report)
has announced the addition of the "9th
Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and
Production" report to their offering.
The 2012 9th Annual Report and Survey of Biopharmaceutical Manufacturing
Capacity and Production is the most recent study of biotherapeutic
developers and contract manufacturing organizations' current and
projected future capacity and production. This year's 9th Annual Report
and Survey of Biopharmaceutical Manufacturing shows the industry has
returned to robust growth.
Based on analysis of 302 global biomanufacturers' 2012 budgets, expect
substantial investment in new technologies that:
- Reduce costs and improve productivity
- Focus on novel downstream technologies
- Improve single-use device adoption rates
This year, among the hundreds of significant findings: Budgets are
growing in all areas measured, but the great majority are continuing to
actively implement cost-cutting initiatives; a broad range of new
products are being demanded from industry vendors to solve productivity
problems, especially in single use and chromatography areas.
Key Features
This report's 471 pages of data-rich analysis will help improve your
decision-making in biomanufacturing operations, with in-depth analysis
of capacity, production trends, benchmarks, and much more:
- Biosimilars pipeline in development
- In-depth analysis of key data, capacity, production trends, and
benchmarks
- Budget trends and impact of current economic environment
- Expression system advances
- Downstream purification problems and issues
- Current and projected industry bottlenecks
- Capacity utilization and current production levels
- How capacity bottlenecks are being resolved
- Production trends and implications for industry
- Outsourcing trends
- International offshoring through 2017
- Range of titres, growth
- Disposables: Spending growth; downstream uses; L&E's; reasons for
increasing/ restricting; budget increases; vendor satisfaction
- Disposables: Compare innovators vs CMOs & US vs Europe
- Batch failure rates & trends
- Selecting a CMO Problems & solutions
- Quality management & PAT implementation
- Hiring and employment growth
- Supplier growth rates
- Much more...
Compare 302 biotherapeutic developers vs CMOs; US vs European & Global
Biomanufacturing
Topics Covered:
- Introduction and Discussion
- Demographics
- Emerging Issues: Budgets, Expression Systems, Operational Changes
- Capacity Utilization
- Current Capacity Constraints
- Future Capacity Expansions
- Outsourcing Trends in Biopharmaceutical Manufacturing
- Disposables and Single-Use Systems in Biopharmaceutical Manufacturing
- Downstream Purification
- Quality Issues, Batch Failures, and PAT in Biopharmaceutical
Manufacturing
- Hiring, Employment Growth, Training
- Suppliers to Biopharmaceutical Manufacturing
For more information visit http://www.researchandmarkets.com/research/4wwjmk/9th-annual-report
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology,
Pharmaceuticals
Source: Research and Markets
|
